Cango (NYSE:CANG) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 73.81 percent increase over losses of $(0.42) per share from the same period last year.
Orgenesis Appoints Finance Veteran Elliot Maltz As Its Chief Financial Officer, Effective September 1, 2023
Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) at the point of care, today announced
